Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com

Add to the disadvantages column - GLP-1 agonists are currently under suspicion of a link to pancreatic cancer.

Share
New Message
Please login to post a reply